blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1668129

EP1668129 - ANTI-ANGIOGENIC PEPTIDES FROM THE N-TERMINUS OF ENDOSTATIN [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  04.09.2009
Database last updated on 19.10.2024
Most recent event   Tooltip07.09.2012Lapse of the patent in a contracting state
New state(s): PT		published on 10.10.2012  [2012/41]
Applicant(s)For all designated states
CHILDREN'S MEDICAL CENTER CORPORATION
300 Longwood Avenue
Boston, Massachusetts 02115 / US
[N/P]
Former [2006/24]For all designated states
CHILDREN'S MEDICAL CENTER CORPORATION
300 Longwood Avenue Boston
Massachusetts 02115 / US
Inventor(s)01 / FOLKMAN, Judah
18 Chatham Street
Brookline, MA 02446 / US
02 / JAVAHERIAN, Kashi
27 Webster Road
Lexington, MA 02421 / US
03 / SJIN, Robert, Tjin, Tham
50 Island View Place, Apt. 310
Dorchester, MA 02125 / US
 [2006/30]
Former [2006/24]01 / FOLKMAN, Judah
18 Chatham Street
Boston, MA 02446 / US
02 / JAVAHERIAN, Kashi
27 Webster Road
Boston, MA 02421 / US
03 / SJIN, Robert, Tjin, Tham
50 Island View Place, Apt. 310
Dorchester, MA 02125 / US
Representative(s)Lee, Nicholas John, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[N/P]
Former [2006/24]Lee, Nicholas John, et al
Kilburn & Strode, 20 Red Lion Street
London WC1R 4PJ / GB
Application number, filing date04782583.130.08.2004
[2006/24]
WO2004US28143
Priority number, dateUS20030499264P29.08.2003         Original published format: US 499264 P
US20040539213P26.01.2004         Original published format: US 539213 P
[2006/24]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2005021756
Date:10.03.2005
Language:EN
[2005/10]
Type: A1 Application with search report 
No.:EP1668129
Date:14.06.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 10.03.2005 takes the place of the publication of the European patent application.
[2006/24]
Type: B1 Patent specification 
No.:EP1668129
Date:29.10.2008
Language:EN
[2008/44]
Search report(s)International search report - published on:EP10.03.2005
ClassificationIPC:C12N15/11, C07K14/78, A61K38/04
[2006/24]
CPC:
A61K38/10 (EP,US); C07K14/435 (KR); A61K38/00 (KR);
A61K38/17 (EP,US); A61P1/04 (EP); A61P15/00 (EP);
A61P17/02 (EP); A61P17/06 (EP); A61P19/02 (EP);
A61P19/08 (EP); A61P27/02 (EP); A61P27/06 (EP);
A61P3/10 (EP); A61P35/00 (EP); A61P35/02 (EP);
A61P35/04 (EP); A61P37/06 (EP); A61P9/04 (EP);
A61P9/10 (EP); A61P9/14 (EP); C07K14/78 (EP,KR,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/24]
Extension statesALNot yet paid
HRNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:ANTIANGIOGENE PEPTIDE VOM N-TERMINUS VON ENDOSTATIN[2006/24]
English:ANTI-ANGIOGENIC PEPTIDES FROM THE N-TERMINUS OF ENDOSTATIN[2006/24]
French:PEPTIDES ANTI-ANGIOGENIQUES COMPRENANT UNE EXTREMITE N-TERMINALE D'ENDOSTATINE[2006/24]
Entry into regional phase27.03.2006National basic fee paid 
27.03.2006Designation fee(s) paid 
27.03.2006Examination fee paid 
Examination procedure27.03.2006Examination requested  [2006/24]
28.03.2006Amendment by applicant (claims and/or description)
13.09.2006Despatch of a communication from the examining division (Time limit: M06)
03.05.2007Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
22.06.2007Reply to a communication from the examining division
26.07.2007Despatch of a communication from the examining division (Time limit: M04)
27.11.2007Reply to a communication from the examining division
25.02.2008Communication of intention to grant the patent
23.06.2008Fee for grant paid
23.06.2008Fee for publishing/printing paid
Opposition(s)30.07.2009No opposition filed within time limit [2009/41]
Request for further processing for:22.06.2007Request for further processing filed
27.06.2007Full payment received (date of receipt of payment)
Request granted
11.07.2007Decision despatched
Fees paidRenewal fee
29.08.2006Renewal fee patent year 03
29.08.2007Renewal fee patent year 04
28.08.2008Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT29.10.2008
BE29.10.2008
CY29.10.2008
CZ29.10.2008
DK29.10.2008
EE29.10.2008
FI29.10.2008
IT29.10.2008
NL29.10.2008
PL29.10.2008
RO29.10.2008
SI29.10.2008
SK29.10.2008
TR29.10.2008
BG29.01.2009
SE29.01.2009
GR30.01.2009
ES09.02.2009
PT29.03.2009
HU30.04.2009
[2012/41]
Former [2011/43]AT29.10.2008
BE29.10.2008
CY29.10.2008
CZ29.10.2008
DK29.10.2008
EE29.10.2008
FI29.10.2008
IT29.10.2008
NL29.10.2008
PL29.10.2008
RO29.10.2008
SI29.10.2008
SK29.10.2008
TR29.10.2008
BG29.01.2009
SE29.01.2009
GR30.01.2009
ES09.02.2009
HU30.04.2009
Former [2011/32]AT29.10.2008
BE29.10.2008
CZ29.10.2008
DK29.10.2008
EE29.10.2008
FI29.10.2008
IT29.10.2008
NL29.10.2008
PL29.10.2008
RO29.10.2008
SI29.10.2008
SK29.10.2008
BG29.01.2009
SE29.01.2009
GR30.01.2009
ES09.02.2009
HU30.04.2009
Former [2010/51]AT29.10.2008
BE29.10.2008
CZ29.10.2008
DK29.10.2008
EE29.10.2008
FI29.10.2008
IT29.10.2008
NL29.10.2008
PL29.10.2008
RO29.10.2008
SI29.10.2008
SK29.10.2008
BG29.01.2009
SE29.01.2009
GR30.01.2009
ES09.02.2009
Former [2009/44]AT29.10.2008
BE29.10.2008
CZ29.10.2008
DK29.10.2008
EE29.10.2008
FI29.10.2008
IT29.10.2008
NL29.10.2008
PL29.10.2008
RO29.10.2008
SI29.10.2008
SK29.10.2008
BG29.01.2009
SE29.01.2009
ES09.02.2009
Former [2009/41]AT29.10.2008
BE29.10.2008
CZ29.10.2008
DK29.10.2008
EE29.10.2008
FI29.10.2008
IT29.10.2008
NL29.10.2008
PL29.10.2008
RO29.10.2008
SI29.10.2008
BG29.01.2009
SE29.01.2009
ES09.02.2009
Former [2009/36]AT29.10.2008
BE29.10.2008
DK29.10.2008
EE29.10.2008
FI29.10.2008
NL29.10.2008
PL29.10.2008
RO29.10.2008
SI29.10.2008
BG29.01.2009
ES09.02.2009
Former [2009/35]AT29.10.2008
BE29.10.2008
DK29.10.2008
FI29.10.2008
NL29.10.2008
PL29.10.2008
SI29.10.2008
BG29.01.2009
ES09.02.2009
Former [2009/32]AT29.10.2008
BE29.10.2008
FI29.10.2008
NL29.10.2008
PL29.10.2008
SI29.10.2008
BG29.01.2009
ES09.02.2009
Former [2009/26]AT29.10.2008
FI29.10.2008
NL29.10.2008
PL29.10.2008
SI29.10.2008
BG29.01.2009
ES09.02.2009
Former [2009/24]AT29.10.2008
FI29.10.2008
BG29.01.2009
ES09.02.2009
Former [2009/20]ES09.02.2009
Cited inInternational search[X]WO9715666  (CHILDRENS MEDICAL CENTER [US]) [X] 1-20 * the whole document *;
 [A]WO9929855  (BETH ISRAEL HOSPITAL [US], et al) [A] 1-20 * the whole document *;
 [A]WO9948924  (CHILDRENS MEDICAL CENTER [US], et al) [A] 1-20 * the whole document *;
 [X]WO9962944  (CHILDRENS MEDICAL CENTER [US]) [X] 1-20 * sequence 4 *;
 [X]WO0011033  (LEXINGEN PHARMACEUTICALS CORP [US]) [X] 1-20 * sequence 37 *;
 [X]WO0026368  (CHILDRENS MEDICAL CENTER [US]) [X] 1-20 * sequence 1 *;
 [X]WO0060945  (MERCK & CO INC [US], et al) [X] 1-20 * sequences 9-12,14,16-19 *;
 [X]WO0067771  (BURNHAM INST [US], et al) [X] 1-20 * sequences 19,63,81 *;
 [A]WO0230982  (ENTREMED INC [US], et al) [A] 1-20 * the whole document *;
 [A]WO02068457  (UNIV DEGLI STUDI MILANO [IT], et al) [A] 1-20* the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.